Patient Guide: Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 128 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06750289
Status: 🟢 Enrolling Now
Condition: Eosinophilic Asthma
Phase: PHASE3

Where You Can Participate

This study is available at 128 locations across the country.

Top locations include:
  • • Chandler, Arizona
  • • Sun City, Arizona
  • • Tucson, Arizona
  • • And 125 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment - Join Clinical Trial NCTNCT06750289

How to Join This Clinical Trial - NCTNCT06750289

Learn how to participate in this PHASE3 trial studying an investigational therapy for Eosinophilic Asthma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Eosinophilic Asthma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Eosinophilic Asthma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06750289 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 128 locations. Find a study site near you:

Clinical Research Site

Chandler, Arizona 85224 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Tucson, Arizona 85704 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Inglewood, California 90301 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Newport Beach, California 92663 - United States

Status: RECRUITING

Clinical Research Site

Pasadena, California 91101 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Denver, Colorado 80206 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Cape Coral, Florida 33990 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Lauderdale Lakes, Florida 33313 - United States

Status: RECRUITING

Clinical Research Site

Leesburg, Florida 34748 - United States

Status: RECRUITING

And 118 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Eosinophilic Asthma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships